BeOne Medicines Ltd. (ONC)
368.53
-5.55
(-1.48%)
USD |
NASDAQ |
Oct 16, 12:04
BeOne Medicines SG&A Expense (TTM) : 2.238B for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 2.238B |
| March 31, 2026 | 2.184B |
| December 31, 2025 | 2.087B |
| September 30, 2025 | 2.032B |
| June 30, 2025 | 1.957B |
| March 31, 2025 | 1.861B |
| December 31, 2024 | 1.829B |
| September 30, 2024 | 1.743B |
| June 30, 2024 | 1.652B |
| March 31, 2024 | 1.603B |
| December 31, 2023 | 1.505B |
| September 30, 2023 | 1.417B |
| June 30, 2023 | 1.375B |
| March 31, 2023 | 1.312B |
| December 31, 2022 | 1.278B |
| September 30, 2022 | 1.255B |
| June 30, 2022 | 1.202B |
| March 31, 2022 | 1.103B |
| December 31, 2021 | 990.12M |
| September 30, 2021 | 891.83M |
| June 30, 2021 | 783.44M |
| March 31, 2021 | 675.20M |
| Date | Value |
|---|---|
| December 31, 2020 | 600.18M |
| September 30, 2020 | 535.32M |
| June 30, 2020 | 479.49M |
| March 31, 2020 | 437.68M |
| December 31, 2019 | 388.25M |
| September 30, 2019 | 317.38M |
| June 30, 2019 | 261.20M |
| March 31, 2019 | 224.12M |
| December 31, 2018 | 195.38M |
| September 30, 2018 | 150.31M |
| June 30, 2018 | 117.13M |
| March 31, 2018 | 82.75M |
| December 31, 2017 | 62.60M |
| September 30, 2017 | 43.52M |
| June 30, 2017 | 32.60M |
| March 31, 2017 | 25.73M |
| December 31, 2016 | 20.10M |
| September 30, 2016 | 14.71M |
| June 30, 2016 | 14.35M |
| March 31, 2016 | 10.44M |
| December 31, 2015 | 7.311M |
| September 30, 2015 | 4.361M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Basilea Pharmaceutica AG | 45.60M |
| Santhera Pharmaceuticals Holding AG | 18.92M |
| AC Immune SA | 19.51M |
| CRISPR Therapeutics AG | 70.07M |
| Idorsia Ltd. | 264.55M |